| __timestamp | Alnylam Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 56292000 |
| Thursday, January 1, 2015 | 276495000 | 74277000 |
| Friday, January 1, 2016 | 382392000 | 122721000 |
| Sunday, January 1, 2017 | 390635000 | 109749000 |
| Monday, January 1, 2018 | 505420000 | 145283000 |
| Tuesday, January 1, 2019 | 655114000 | 131711000 |
| Wednesday, January 1, 2020 | 654819000 | 181157000 |
| Friday, January 1, 2021 | 792156000 | 272744000 |
| Saturday, January 1, 2022 | 883015000 | 397518000 |
| Sunday, January 1, 2023 | 1004415000 | 571011000 |
| Monday, January 1, 2024 | 1126232000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Alnylam Pharmaceuticals, Inc. and Insmed Incorporated have been at the forefront of this race.
Since 2014, Alnylam has consistently outpaced Insmed in R&D investments, with a staggering 428% increase by 2023. This commitment to innovation is evident in their groundbreaking work in RNA interference therapeutics.
While Insmed's R&D spending has grown by 914% over the same period, it remains less than half of Alnylam's 2023 expenditure. However, Insmed's focus on rare diseases and orphan drugs positions it uniquely in the market.
As both companies continue to invest heavily in R&D, the biotech industry can expect significant advancements in treatment options, promising a healthier future for patients worldwide.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Alnylam Pharmaceuticals, Inc.
R&D Spending Showdown: AbbVie Inc. vs Alnylam Pharmaceuticals, Inc.
R&D Insights: How Alnylam Pharmaceuticals, Inc. and Perrigo Company plc Allocate Funds
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Veracyte, Inc.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Grifols, S.A.
Research and Development Expenses Breakdown: Insmed Incorporated vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Dynavax Technologies Corporation
Insmed Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Evotec SE